A UNIQUE WAY TO CREATE AWARENESS ABOUT BONE HEALTH Attendees of Toronto Fashion Week saw something unusual on the catwalk this year: a line of innovative fashions incorporating bubble wrap! […]
Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]
Prepared and reviewed by members of the Scientific Advisory Council of Osteoporosis Canada • Dr. Rick Adachi, Rheumatologist, McMaster University • Dr. Robert Josse, Endocrinologist, University of Toronto • Dr. […]
IMPACT REPORT 2017 “I thought my active lifestyle would insulate me from such things.” Colm MEET JOANNE & COLM When Joanne Kelly was diagnosed with osteoporosis in 2007, she wished […]
IMPACT REPORT 2019 – 2020 PATIENT STORY: MEET MURRAY BOLTON For Murray, it all started with a broken wrist. The kind of accident that could happen to anyone, he reasoned. […]
No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]
We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]
